Protagonist Therapeutics: Q4 Earnings Snapshot
Unsurprisingly, Johnson & Johnson's top investments are all in the healthcare sector.
Protagonist Therapeutics: Q3 Earnings Snapshot
FN Media Group Presents USA News Group News Commentary  Vancouver, BC – September 22, 2023 – USA News Group  – Despite the potential federal funding challenges due to the recent debt ceiling...
/PRNewswire/ -- USA News Group - Despite the potential federal funding challenges due to the recent debt ceiling deal, optimism in the battle against cancer...
USA News Group – Despite the potential federal funding challenges due to the recent debt ceiling deal, optimism in the battle against cancer persists, thanks in large part to the audacious “Cancer...
Protagonist Therapeutics: Q2 Earnings Snapshot
With Biomea Fusion's share price nearly halved recently, oversold conditions seem to be setting in. This could be an opportunity for small cap growth investors.
The Chart of the Day belongs to the biopharmaceutical company Protagonist Therapeutics (PTGX) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical...
/PRNewswire/ -- Protagonist Therapeutics (Nasdaq: PTGX) ("Protagonist" or "the Company") reported data from its collaboration with Janssen Biotech, Inc., one...